Substituted 7-azabicyclo[2.2.1]heptyl Derivatives Useful for Making Pharmaceutical Compositions
This invention provides 1-substituted-7-azabicyclo[2.2.1]heptyl derivatives, intermediates and methods for producing them, which are therapeutic agents useful for the prevention and treatment of central nervous system disorders and diseases mediated by a Nicotinic Acetylcholine Receptor such as Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy, pain, nicotine addiction and dementia.
Patents:US 20,100,093,807
Inventor(s):
STEVENS CHRISTIAN [BE]; DE BLIECK ANN [BE]; HEUGEBAERT THOMAS [BE]
Type of Offer:
Sale
« More Biotech Patents